Perfusion-UK

Papers
(The H4-Index of Perfusion-UK is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-09-01 to 2024-09-01.)
ArticleCitations
ECMO in COVID-19—prolonged therapy needed? A retrospective analysis of outcome and prognostic factors48
Systemic immune inflammation index: a novel predictor for coronary collateral circulation23
ECMO support in SARS-CoV2 multisystem inflammatory syndrome in children in a child21
Prognostic nutritional index predicts in-hospital mortality in patients with acute Stanford type A aortic dissection20
Cytosorb® hemoadsorption of apixaban during emergent cardio-pulmonary bypass: a case report18
Managing Harlequin Syndrome in VA-ECMO – do not forget the right ventricle17
The novel ProtekDuo ventricular assist device: Configurations, technical aspects, and present evidence17
Hsa_circ_0001445 inhibits ox-LDL-induced HUVECs inflammation, oxidative stress and apoptosis by regulating miRNA-64016
Syringin protects against cerebral ischemia/reperfusion injury via inhibiting neuroinflammation and TLR4 signaling15
International survey of neuromonitoring and neurodevelopmental outcome in children and adults supported on extracorporeal membrane oxygenation in Europe15
Enhanced recovery after cardiac surgery and its impact on outcomes: A systematic review14
Use of bivalirudin for anticoagulation in pediatric extracorporeal membrane oxygenation (ECMO)13
Inter-hospital COVID ECMO air transportation13
Hypercoagulopathy, acquired coagulation disorders and anticoagulation before, during and after extracorporeal membrane oxygenation in COVID-19: a case series13
Enabling the control of reperfusion parameters in out-of-hospital cardiac arrest: First applications of the CARL system13
0.089530944824219